Philadelphia, 16 - 17 September 2025

Schedule

Create your personal agenda –check the favourite icon

Sep 168:55
Conference pass

Chair remarks

Keynotes
Julie Huxley-Jones, Vice President, Research, BSMO, Preclinical Technology, Vertex Pharmaceuticals
Sep 1611:40
Conference pass

Chair remarks

Rare Diseases in Genomics
Catherine Brownstein, Assistant Professor, Harvard Medical School
Sep 1611:40
Conference pass

Chair remarks

AI in Drug Development and Discovery
Sep 1611:40
Conference pass

Chair remarks

Bioinformatics + in silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1611:40
Conference pass

Chair remarks

Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson cancer center
Sep 1611:40
Conference pass
Sep 1611:45
Conference pass

Rare disease discovery infrastructure at a tertiary children’s hospital

Rare Diseases in Genomics
Catherine Brownstein, Assistant Professor, Harvard Medical School
Sep 1611:45
Conference pass

Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D

AI in Drug Development and Discovery
Sep 1611:45
Conference pass

Utilizing large-scale biobank-based human circulating proteomics and genetics to enhance novel therapeutic target discovery

Bioinformatics + in silico R&D
Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard
Sep 1611:45
Conference pass

From Data to Diagnosis: The Impact of Large Language Models in Medical AI

Large Language Models
Hemachandran Kannan, Director - AI Research Centre, Woxsen University
Sep 1611:45
Conference pass

Risk assessment for prevention

Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson cancer center
Sep 1611:45
Conference pass

Digital transformation through co-pilots and agile upskilling

Digital Transformation
John Wright, Director of Engineering, Research and Development Informatics, Amgen
Sep 1611:45
Conference pass

Secondary use of data to generate insights

Data Management, Storage and Architecture
Christina Lu, Global Head Data Curation and Integration, Genentech
Sep 1611:45
Conference pass

A practical look at data governance in life sciences

Data Integration + FAIR
Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1611:45
Conference pass

Intelligent Trials: How AI is Redefining the Clinical Research Landscape

AI in Clinical Trials
Sep 1611:45
Conference pass

Preparing the biotech workforce of the future: the role of academic partnerships

Real World Evidence
Ikhide Imumorin, Executive Director, California State University
Sep 1612:25
Conference pass

Strategic pipeline development and protaminase strategy for rare disease and integrative genomics

Rare Diseases in Genomics
Cynthia Brysch, Director of Quality Assurance and Regulatory Affairs, Horizon
Sep 1612:25
Conference pass

Biological sequence learning at GSK.AI

AI in Drug Development and Discovery
Ari Allyn-Feuer, Director of Artificial Intelligence Product, GSK
Sep 1612:25
Conference pass

Multi-omics and AI for target identification and validation

Bioinformatics + in silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1612:25
Conference pass

Using large language models to develop immunotherapies for oncology

Large Language Models
Sep 1612:25
Conference pass

Oncology Translational Research with Real-World Data and Machine Learning: Study of Resistance to Immune Therapy in Non Small Cell Lung Cancer (NSCLC)

Big Data in Oncology
Paola Correa, Bioinformatics Specialist, Gilead Sciences
Sep 1612:25
Conference pass

From Complexity to Clarity: Standardizing Data for Innovation in Biotech

Data Management, Storage and Architecture
Kenneth Schwartz, VP, Global Data, Genmab
Sep 1612:25
Conference pass

Implantation of digital transformation

Digital Transformation
Yaiza Peraza, Data Capabilities Lead, Novo Nordisk
Sep 1612:25
Conference pass

Pitfalls and Best Practices: Notes from the (research) field

Data Integration + FAIR
Lori Hoepner, Asst Professor, SUNY DOWNSTATE
Sep 1612:25
Conference pass

AI in Clinical Trials

AI in Clinical Trials
Preetha Ram, Managing Partner, Pier 70 Ventures
Sep 1612:25
Conference pass

Real-time prediction of postoperative adverse events in ICU

Real World Evidence
Qingchu Jin, Research Scientist, Northeastern University
Sep 1613:05
Conference pass

Using genetic tools to find a cure for rare diseases

Rare Diseases in Genomics
Xiao Wang, Research Assistant Professor, Univeristy Of Pennsylvania
Sep 1613:05
Conference pass

Center for Data-Driven Drug Development and Treatment Assessment (DATA): A National Center to Promote AI for Drug Design and Assessment

AI in Drug Development and Discovery
Kayvan Najarian, Professor, University of Michigan, Ann Arbor
Sep 1613:05
Conference pass

Harnessing Radiology and Radiomics Data for Data Science

Big Data in Oncology
Fengjian Shi, Product Owner - Oncology Data Science, AstraZencea
Sep 1613:05
Conference pass

Designing and developing R&D platforms

Data Management, Storage and Architecture
Jagat Adhiya, VP Head of Digital Transformation & IT, Bayer
Sep 1613:05
Conference pass

Digital transformation in Aggregate Reporting

Digital Transformation
Rupesh Kumar Polupongu, Senior Manager, Global Safety Data Management, Otsuka Pharmaceutical
Sep 1613:05
Conference pass

Open access resources for genetic and genomic

Data Integration + FAIR
Noel Burtt, Director Of Operations, Diabetes Research, Broad Institute of M.I.T. & Harvard
Sep 1613:05
Conference pass

AI as a Powerful Ally: Empowering Clinical Professionals in Trials and Healthcare Research

AI in Clinical Trials
Sep 1613:05
Conference pass

Leveraging RWD in the Drug Development Process

Real World Evidence
Thomas Dougherty, Data Science & AI Innovative Partnership Lead, Novo Nordisk
Sep 1614:25
Conference pass

Chair remarks

AI in Drug Development and Discovery
Sandra Barbosu, Associate Director, Information Technology and Innovation Foundation
Sep 1614:25
Conference pass

Chair remarks

Bioinformatics + in silico R&D
Abhijeet R Patil, Manager, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1614:25
Conference pass

Chair remarks

Large Language Models
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1614:25
Conference pass

Chair remarks

Digital Transformation
Soo Son, Health Equity Advocate, Unlocking Eve
Sep 1614:25
Conference pass

Chair remarks

AI in Clinical Trials
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1614:30
Conference pass

Data, AI and the patient advocate

Rare Diseases in Genomics
Neena Nizar, President and Founder, The Jansens Foundation
Sep 1614:30
Conference pass

Gen AI powering Medical and Patient Safety reviews

AI in Drug Development and Discovery
Sunil Talathi, Senior Director, Global Head - Data Science & AI, BeiGene
Sep 1614:30
Conference pass

Single cell genomics in drug discovery

Bioinformatics + in silico R&D
Abhijeet R Patil, Manager, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1614:30
Conference pass

Implementing GenAI Sustainably at Enterprise Scale

Large Language Models
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1614:30
Conference pass

Leveraging pathology translational models for TLS detection in solid tumors

Big Data in Oncology
Meijian Guan, Associate Director Translational Data Science, Genmab
Sep 1614:30
Conference pass

Connected content driving digital transformation

Digital Transformation
Anthony Figorski, Senior Director, Business Transformation, AstraZeneca
Sep 1614:30
Conference pass

Developing a harmonized data ecosystem to accelerate cancer research at the Sylvester Comprehensive Cancer Center

Data Integration + FAIR
Vasileios Stathias, Assistant Director, Data Science, UNIVERSITY OF MIAMI
Sep 1614:30
Conference pass

Responsible AI

AI in Clinical Trials
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1614:30
Conference pass

Clinical utility of rapid diagnostics for infectious diseases

Real World Evidence
Rebecca Yee, Chief of Microbiology, Assistant Professor of Pathology, The George Washington University
Sep 1614:50
Conference pass

AI and clinical trials to automate the documentation process

AI in Clinical Trials
Chris Willis, Director, Emerging Method & Technologies - Research IT, Bristol Myers Squibb
Sep 1615:10
Conference pass

Quantum Computing beyond the hype - what is possible and when will it finally be useful?

AI in Drug Development and Discovery
Johannes Galatsanos, Researcher at Center of Quantum Networks, Massachusetts Institute of Technology
Sep 1615:10
Conference pass

LLM’s in medical affairs

Large Language Models
Kausar Riaz Ahmed, Director, Generative AI Medical Engagement Lead, Pfizer
Sep 1615:10
Conference pass

DNA Methylation-Mediated Epigenetic Adaptation Promotes Cellular Resilience In AML

Big Data in Oncology
Manna Ahmed, Assistant Research Professor - Manager of The Genomics Resource Facility, Fox Chase Cancer Center
Sep 1615:10
Conference pass

Data and its architecture

Data Management, Storage and Architecture
Venkat Sanka, Data Analytics and Data Governance Consultant, Johnson & Johnson
Sep 1615:10
Conference pass

Novel meta data management for drug discovery

Digital Transformation
Mark Ziman, Senior Product Manager, GSK
Sep 1615:10
Conference pass

AI-powered multi-omics data integration for predictive modeling of drug actions

Data Integration + FAIR
Lei Xie, Professor, Hunter College of CUNY
Sep 1615:10
Conference pass

Clinical Trials in AI

AI in Clinical Trials
Ritesh Shah, Clinical Oncology Informatics Pharmacist, Penn Medicine
Sep 1615:10
Conference pass

Advancing the Clinical Trial Ecosystem: MENA’s Strategic Role in Enhancing Global Inclusivity

Real World Evidence
Huda Eldosougi, Chief Technical Advisor, Saudi food and drug authority
Sep 1615:30
Conference pass

Leveraging technology to revolutionise drug discovery and development

Digital Transformation
Ryan Pehrson, Head of Infrastructure & Cloud, Takeda
Sep 1615:50
Conference pass

Navigating launch challenges in rare disease markets

Rare Diseases in Genomics
Soumavo Sarkar, Director, Novartis
Sep 1615:50
Conference pass

LATTE: Federated Lossless Algorithms for Target Trial Emulation Using Decentralized Real-world Data For Drug Repurposing

AI in Drug Development and Discovery
Yong Chen, Professor of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania School Of Medicine
Sep 1615:50
Conference pass

Generative AI driven clinical trials

Large Language Models
Kevin Lee, Senior Director of Biometrics and Data Science, Bristol Myers Squibb
Sep 1615:50
Conference pass

Digital transformation in AI

Digital Transformation
Richa Gulati, Senior Product Manager AI, Johnson & Johnson
Sep 1615:50
Conference pass

Seamlessly Connecting the Dots: Advancing Data Integration for Precision Medicine and Drug Discovery

Data Integration + FAIR
Craig Stanley, VP Data Strategy and Technical Operations, Institute for Neurodegenerative Disorders
Sep 1615:50
Conference pass

AI in protocol authorization informing amendments and protocol optimizationAI in protocol authorization informing amendments and protocol optimization

AI in Clinical Trials
Mukul Virmani, Director, Clinical Data Science, Advanced Analytics, Gilead Sciences, Inc.
Sep 1615:50
Conference pass

The role of a control arm in rare disease therapy clinical trials

Real World Evidence
Mitra Tavakkoli, Executive Medical Director, Bridge Bio
Sep 1616:40
Conference pass
Sep 1616:40
Conference pass

Chair remarks

Digital Transformation
Vivek Mukhatyar, GenAI Medical Engagement Lead, Pfizer
Sep 1616:45
Conference pass

Publications and Medical Communications in the Digital Age and Post-Pandemic

Rare Diseases in Genomics
Sep 1616:45
Conference pass

The journey of Takeda connected clinical systems and use of practical AI

Large Language Models
Harish Manmathan, Director of Clinical Data Engineering, Takeda
Sep 1616:45
Conference pass

Digital transformation planning and stakeholder buy in

Digital Transformation
Sep 1616:45
Conference pass

The All of Us research programme - a platform to transform biomedical research

Data Integration + FAIR
Sep 1616:45
Conference pass

AI powered Clinical trial integration in the medical affairs field

AI in Clinical Trials
Sara Hammad, US Associate Medical Director - Transplantation, Sanofi
Sep 1616:45
Conference pass

Understanding complex diseases to identify the right targets

Real World Evidence
Michael Liebman, Managing Director and Co-Founder, IPQ Analytics, LLC
Sep 1617:05
Conference pass

Lab Automation & AI Accelerated Drug Discovery

Digital Transformation
Peter Clark, VP, Computational Drug Deaign, Novo Nordisk
Sep 1617:25
Conference pass

Data in rare disease and the changing landscape

Rare Diseases in Genomics
Moderator: Neena Nizar, President and Founder, The Jansens Foundation
Mitra Tavakkoli, Executive Medical Director, Bridge Bio
Sep 1617:25
Conference pass

Disease specific foundational models

AI in Drug Development and Discovery
Moderator: Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1617:25
Conference pass

Using bioinformatics + InSilco to optimise research and development

Bioinformatics + in silico R&D
Deidre Dalmas Wilk, Scientific Director, Global Investigative Safety, Nonclinical Safety Project Lead, GSK
Sep 1617:25
Conference pass

Generative AI in healthcare

Large Language Models
Moderator: Abhishek Pandey, Global Lead and Principal Research Scientist II, AbbVie
Kausar Riaz Ahmed, Director, Generative AI Medical Engagement Lead, Pfizer
Kevin Lee, Senior Director of Biometrics and Data Science, Bristol Myers Squibb
Kritika Gulati, Corporate Faculty, Harrisburg University Of Science And Technology
Sally Wang Liang, Venture Partner, Highlight Capital
Sep 1617:25
Conference pass

Bringing together disbarred data in oncology

Big Data in Oncology
Moderator: Paul Petraro, Head Real-World Evidence Analytic COE, Global Medical Affairs, Boehringer Ingelheim Pharma Inc.
Sep 1617:25
Conference pass

Digital transformation in life science companies

Digital Transformation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Sairam Menon, Sr Manager, AI Product Group Engineering, J&J Innovative Medicine
Sep 1617:25
Conference pass

Enhancing FAIR – Successes and Failures

Data Integration + FAIR
Moderator: Lori Hoepner, Asst Professor, SUNY DOWNSTATE
Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1617:25
Conference pass

Current regulatory standards within AI adoption and its reflection in clinical trial development and execution

AI in Clinical Trials
Moderator: Cynthia Brysch, Director of Quality Assurance and Regulatory Affairs, Horizon
Kevin Stevens, Head, Global Regulatory Affairs Device, PDT, Takeda
Vivek Suryanarayanan, Product Management, Takeda
Sep 1617:25
Conference pass

Leveraging RWE data to improve health equity

Real World Evidence
Moderator: Jin Lee, Investor, Oxford angel fund
Afraim Botros, Director, Field HEOR RWE Research, Bristol Myers Squibb

Create your personal agenda –check the favourite icon

Sep 178:55
Conference pass
Sep 1711:40
Conference pass

Chair remarks

Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:45
Conference pass

Applications for future use of AI

AI in Drug Development and Discovery
Abhishek Pandey, Global Lead and Principal Research Scientist II, AbbVie
Sep 1711:45
Conference pass

Large language models for biomedical applications

Large Language Models
Hua Xu, Assistant Dean, Yale University School of Medicine
Sep 1711:45
Conference pass

Digital transformation in biotherapeutics discovery

Digital Transformation
Alexander Horspool, Associate Director of Data and Laboratory Automation in Biotherapeutics Discovery, Boehringer Ingelheim
Sep 1711:45
Conference pass

The Scope of Fair Data

Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:45
Conference pass

Optimizing clinical trial delivery with gen AI

AI in Clinical Trials
Vivek Suryanarayanan, Product Management, Takeda
Sep 1711:45
Conference pass

From Real-World Data to Real-World Evidence

Real World Evidence
Xiaozhou Fan, Sr. Director, Head of Real-World Evidence, Jazz Pharmaceuticals
Sep 1711:45
Conference pass

How we utilise AI in liquid biopsy

Precision Medicine and Liquid Biopsy
Raluca Predoiu, Companion Diagnostic Strategy Lead, AbbVie
Sep 1712:05
Conference pass

Approaches to precision therapeutics and clinical trial enhancements

Precision Medicine and Liquid Biopsy
Mary Helen Black, SVP and Head of Genomics, Foresite Labs
Sep 1712:25
Conference pass

Software Research and Startups for Biomolecule Analysis and Healthy Aging

AI in Drug Development and Discovery
Sep 1712:25
Conference pass

Single cell genomics and large language models

Bioinformatics + in silico R&D
Qi Song, Senior Scientist, Bristol Myers Squibb
Sep 1712:25
Conference pass

Integration of LLMs with the drug discovery development

Large Language Models
Etai Jacob, Senior Director, Head of Data Science and AI, Early Oncology, AstraZeneca
Sep 1712:25
Conference pass

Digital twins into manufacturing

Digital Transformation
Parag Dave, Head of Data, Digital, and Technology, Takeda
Sep 1712:25
Conference pass

AI and precision medicine for clinical trial development

AI in Clinical Trials
Yilin Xu, Associate Director, AbbVie
Sep 1712:25
Conference pass

Study Visualization to support patient centricity

Real World Evidence
Betsy luo, IT Business Analyst, Astrazeneca
Sep 1712:25
Conference pass

Current state of precision medicine and liquid biopsy and where it is going

Precision Medicine and Liquid Biopsy
Jeffrey Lee, Associate Director of Cloud Architecture, Takeda
Sep 1712:45
Conference pass

Digital and computational pathology in clinical medicin

Precision Medicine and Liquid Biopsy
Nirmit Kumar, Senior Global Medical Strategy Leader, AstraZeneca
Sep 1713:05
Conference pass

Revolutionizing Drug Development: The Role of AI in Accelerating Discovery and Precision Medicine

AI in Drug Development and Discovery
Vineet Jain, IT Partner, Bristol Myers Squibb
Sep 1713:05
Conference pass

Analysis of engagement conversations between MLS and healthcare providers

Large Language Models
Sep 1713:05
Conference pass

Advancing Personalization in Healthcare Professional Omnichannel Communications

Digital Transformation
Donna Judd, Medical Channel Strategy & Engagement Lead, Pfizer
Sep 1713:05
Conference pass

AI-driven trial design and optimization

AI in Clinical Trials
Sep 1713:05
Conference pass

Broadening participation in precision medicine and pharmacogenomics

Precision Medicine and Liquid Biopsy
Simeón Baker, Executive Director of External Affairs, Genomics England
Sep 1714:25
Conference pass

Chair remarks

Data Integration + FAIR
Philip Brown, Senior Data Engineer, Sanofi
Sep 1714:30
Conference pass

Hypothesis Driven Development

AI in Drug Development and Discovery
Dale Kloefkorn, Principal Product Manager, Pfizer
Marcie Stoetzel, Principal Data Product Manager- Enterprise MDM, Pfizer
Sep 1714:30
Conference pass

The road to clinical speech and language analysis

Large Language Models
Sep 1714:30
Conference pass

Game changing digital enabling tools, empowering seamless cross functional collaboration

Digital Transformation
Sep 1714:30
Conference pass

Electronic batch record data translation

Data Integration + FAIR
Philip Brown, Senior Data Engineer, Sanofi
Sep 1714:30
Conference pass

Multi-omics Research and Early-stage Startups in Precision Medicine

Precision Medicine and Liquid Biopsy
Sep 1714:50
Conference pass

Future of innovation and precision medicine

Precision Medicine and Liquid Biopsy
Sep 1715:10
Conference pass

Harnessing AI to Bridge Skills Gaps and Drive Smart Biomanufacturing: Preparing the Biopharma Workforce for the Future of Drug Development

AI in Drug Development and Discovery
Sep 1715:10
Conference pass

Change management with generative AI

Large Language Models
Vivek Mukhatyar, GenAI Medical Engagement Lead, Pfizer
Sep 1715:10
Conference pass

Advancing care for animals in Zoetis through digital transformation

Digital Transformation
Susan Huse, Research Director, Zoetis
Sep 1715:10
Conference pass

Potential paradigm shift in immune-oncology strategies: Synergistic combination of B-cell epitope peptide vaccines and immune checkpoint inhibitor (PD-1, PD-L1, CTLA-4, TIGIT and VEGF) vaccines

Precision Medicine and Liquid Biopsy
Pravin Kaumaya, Professor & Director, Indiana university School of Medicine
last published: 24/Feb/25 17:15 GMT

Get involved at BioTechX USA

 

 

TO SPONSOR


Joshua Kennedy

joshua.kennedy@terrapinn.com

 

TO SPEAK


Anna Abiola
anna.abiola@terrapinn.com

 

MARKETING OPPORTUNITIES


Karen Duncan

karen.duncan@terrapinn.com